Skip to main content
SpringerLink
Log in

Physiological Rationale for Renal Denervation Therapy in Hypertension

  • Chapter
  • First Online:
Renal Denervation

  • 920 Accesses

Abstract

Systemic hypertension is of major importance world-wide due to its significant public health implications. Hypertension is a common clinical disorder encountered not just in the western or industrialized world but also in underdeveloped and emerging countries. In most populations (at least in the western hemisphere) one in three individuals have hypertension and hence it is the largest contributor to excessive mortality and morbidity. Hypertension is a merciless killer without sparing the attributes of age, gender, and socio-economic status. Despite remarkable advances in the physiology, and pharmacology of hypertension, blood pressure (BP) control rates are quite low globally. Whatever the reasons may be, most patients with hypertension fail to achieve recommended goal BP levels.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Brook RD, Julius S. Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens. 2000;13:112S–22.

    Article  CAS  PubMed  Google Scholar 

  2. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, Anderson W, Lambert G. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension. 1988;11:3–20.

    Article  CAS  PubMed  Google Scholar 

  3. Esler M, Jennings G, Lambert G, Meredith I, Horne M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev. 1990;70:963–85.

    CAS  PubMed  Google Scholar 

  4. Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens. 1989;2:140S–6.

    CAS  PubMed  Google Scholar 

  5. Esler M. The sympathetic system and hypertension. Am J Hypertens. 2000;13:99S–105.

    Article  CAS  PubMed  Google Scholar 

  6. Esler M, Jennings G, Biviano B, et al. Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol. 1986;8:S39–43.

    Article  PubMed  Google Scholar 

  7. Kim JR, Kiefe CI, Liu K, Williams OD, Jacobs Jr DR, Oberman A. Heart rate and subsequent blood pressure in young adults: the CARDIA study. Hypertension. 1999;33:640–6.

    Article  CAS  PubMed  Google Scholar 

  8. Mark AL. The sympathetic nervous system in hypertension: a potential long-term regulator of arterial pressure. J Hypertens Suppl. 1996;14:S159–65.

    CAS  PubMed  Google Scholar 

  9. Chapleau MW, Hajduczok G, Abboud FM. Mechanisms of resetting of arterial baroreceptors: an overview. Am J Med Sci. 1988;295:327–34.

    Article  CAS  PubMed  Google Scholar 

  10. Hollenburg NK, Adams DF, Solomon H, Chenitz WR, Burger BM, Abrams HL, et al. Renal vascular tone in essential and secondary hypertension: hemodynamic and angiographic responses to vasodilators. Medicine (Baltimore). 1975;54:29–44.

    Article  Google Scholar 

  11. Katholi RE. Renal nerves in the pathogenesis of hypertension in experimental animals and humans. Am J Physiol. 1983;245:F1–14.

    CAS  PubMed  Google Scholar 

  12. Di Bona GF, Kopp UC. Neural control of renal function. Physiol Rev. 1997;77:76–155.

    Google Scholar 

  13. Luff SE, Hengstberger SG, McLachlan EM, Anderson WP. Distribution of sympathetic neuroeffector junctions in the juxtaglomerular region of the rabbit kidney. J Auton Nerv Syst. 1992;40:239–53.

    Article  CAS  PubMed  Google Scholar 

  14. Hering D, Zdrojewski Z, Krol E, Kara T, Kucharska W, Somers VK, Rutkowski B, Narkiewicz K. Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. J Hypertens. 2007;25:157–61.

    Article  CAS  PubMed  Google Scholar 

  15. Di Bona GF. Neural control of the kidney: past, present, and future. Hypertension. 2003;41:621–4.

    Article  Google Scholar 

  16. Di Bona GF. Sympathetic nervous system influences on the kidney: role in hypertension. Am J Hypertens. 1989;2(Suppl):119S–24.

    Google Scholar 

  17. Barajas L, Liu L, Powers K. Anatomy of the renal innervation: Intrarenal aspects and ganglia of origin. Can J Physiol Pharmacol. 1992;70:735–49.

    Article  CAS  PubMed  Google Scholar 

  18. Barajas L, Muller J. The innervation of the juxtaglomerular apparatus and surrounding tubules. A quantitative analysis by serial section electron microscopy. J Ultrastruct Res. 1973;43:107–32.

    Article  CAS  PubMed  Google Scholar 

  19. Kopp UC, Cicha MZ, Smith LA. Impaired interaction between efferent and afferent renal nerve activity in SHR involves increased activation of alpha2-adrenoceptors. Hypertension. 2011;57:640–7.

    Article  CAS  PubMed  Google Scholar 

  20. Kopp UC. Renorenal reflexes: neural and functional responses. Fed Proc. 1985;44:2834–9.

    CAS  PubMed  Google Scholar 

  21. Caverson MM, Ciriello J. Effect of stimulation of afferent renal nerves on plasma levels of vasopressin. Am J Physiol. 1987;252:R801–7.

    CAS  PubMed  Google Scholar 

  22. Holmer S, Rinne B, Eckardt KU, Le Hir M, Schricker K, Kaissling B, Riegger G, Kurtz A. Role of renal nerves for the expression of renin in adult rat kidney. Am J Physiol. 1994;266:F738–45.

    CAS  PubMed  Google Scholar 

  23. Doumas M, Faselis C, Papademetriou V. Renal sympathetic denervation and systemic hypertension. Am J Cardiol. 2010;105:570–6.

    Article  PubMed  Google Scholar 

  24. Hering D, Lambert EA, Marusic P, Walton AS, Krum H, Lambert GW, Esler MD, Schlaich MP. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension. Hypertension. 2013;61:457–64.

    Article  CAS  PubMed  Google Scholar 

  25. Krum H, Schlaich M, Whitbourn R, et al. Catheter-based renal sympathetic denervation for resistant hypertension. A multicentre safety and proof-of-principle cohort study. Lancet. 2009;373:1275–81.

    Article  PubMed  Google Scholar 

  26. Morrissey DM, Brookes VS, Cooke WT. Sympathectomy in the treatment of hypertension: review of 122 cases. Lancet. 1953;1:403–8.

    Article  CAS  PubMed  Google Scholar 

  27. Smithwick RH, Thompson JE. Splanchnicectomy for essential hypertension: results in 1,266 cases. JAMA. 1953;152:1501–4.

    Article  CAS  Google Scholar 

  28. Smithwick RH. Hypertensive vascular disease: results of and indications for splanchnicectomy. J Chronic Dis. 1955;1:477–96.

    Article  CAS  PubMed  Google Scholar 

  29. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months. Hypertension. 2011;57:911–7.

    Article  Google Scholar 

  30. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension. (The Symplicity HTN-2 Trial): a randomized controlled trial. Lancet. 2010;376:1903–9.

    Article  Google Scholar 

  31. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932–4. doi:10.1056/NEJMc0904179.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Apollo Institute for Blood Pressure Management, Apollo Blood Pressure Clinics, Apollo Hospitals, Hyderabad, AP, India

    C. Venkata S. Ram MD, MA, CP, FACC

  2. Texas Blood Pressure Institute, Medical School, University of Texas Southwestern, Dallas, TX, USA

    C. Venkata S. Ram MD, MA, CP, FACC

  3. Cardiology Department, Continental Hospitals, Hyderabad, AP, India

    A. Sreenivas Kumar

Authors
  1. C. Venkata S. Ram MD, MA, CP, FACC
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Sreenivas Kumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C. Venkata S. Ram MD, MA, CP, FACC .

Editor information

Editors and Affiliations

  1. St. Luke's Medical Center, Phoenix, Arizona, USA

    Richard R. Heuser

  2. Baker IDI Heart and Diabetes Institute, Melbourne, Victoria, Australia

    Markus Schlaich

  3. CardioVascular Center Frankfurt Sankt Katharinen, Frankfurt, Germany

    Horst Sievert

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Ram, C.V.S., Kumar, A.S. (2015). Physiological Rationale for Renal Denervation Therapy in Hypertension. In: Heuser, R., Schlaich, M., Sievert, H. (eds) Renal Denervation. Springer, London. https://doi.org/10.1007/978-1-4471-5223-1_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-5223-1_2

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-5222-4

  • Online ISBN: 978-1-4471-5223-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation